B-Side

Peptide Wave

Your Body Was Trying to Tell You. We Finally Started Listening.

You know someone on it. I do too.

Ozempic. Wegovy. Zepbound. Mounjaro. Names that didn’t exist in most people’s vocabulary five years ago and are now in casual conversation at brunch. Friend lost forty pounds. Coworker dropped two pant sizes. Cousin can’t stop talking about how she just isn’t hungry anymore.

The numbers are staggering. Millions of people are on these medications. The cultural conversation has shifted so fast that it’s hard to remember a time when “GLP-1” wasn’t a phrase regular people used.

But here’s what most people don’t know — or haven’t really thought about. These drugs aren’t weight loss medications. Not really. They’re peptide mimics. They’re copies of a small molecule your body was supposed to be making on its own.

A Quick Word About Peptides

A peptide is a short chain of amino acids. Your body makes thousands of them every day. They’re messengers — tiny signals that travel through your bloodstream telling different parts of you what to do and when. Eat. Stop eating. Sleep. Wake up. Store fat. Burn fat. Calm down. Pay attention.

GLP-1 — glucagon-like peptide 1 — is one of these messengers. Its job is to tell your brain you’re full and to slow your digestion. When your body makes enough of it, you naturally stop eating when you’ve had enough. When it doesn’t, you don’t.

Ozempic and the rest of the GLP-1 drugs work by leaving the message your body forgot to leave. They’re not adding something foreign to your system. They’re filling in for a signal that should have been there all along.

That distinction matters. We tend to think of medications as outside intervention. But these are different. They’re synthetic versions of something your own biology was built to produce. The drug isn’t replacing your system — it’s standing in for a part of it that went quiet.

What Stanford Just Found

Last week, Stanford researchers published something that didn’t get nearly the attention it deserved.

Using AI, they scanned all 20,000 human protein-coding genes looking for peptides we hadn’t identified yet. The body produces thousands of these messengers, and most of them have never been studied because there are too many to track manually. So they let the algorithm do the looking.

It found one. A tiny peptide made of just twelve amino acids. They named it BRP.

When they tested it in animals, BRP did what GLP-1 does — reduced appetite, drove weight loss, improved insulin sensitivity. But it did it differently. GLP-1 receptors live in the brain and the gut, and the pancreas, which is why Ozempic causes nausea, constipation, and muscle loss. BRP appears to act only in the hypothalamus — the brain’s appetite control center. No gut effects. No nausea. No muscle loss.

Same job. Different mechanism. Cleaner outcome.

And here’s the part that hit me: the body has been making BRP all along. We just didn’t know to look for it. AI didn’t invent the molecule. It found one that was already there, hiding in plain sight, doing its job quietly while we were busy synthesizing imitations of a different peptide that came with side effects.

The Pattern

I keep noticing this pattern. The body, the kitchen, the natural system — they keep turning out to have answers we’d been looking for elsewhere.

Tallow had everything we were trying to engineer into seed oils. Soil bacteria had the immune support we were trying to bottle. Saliva had the digestive enzymes we were buying as supplements. Fiber was always in the food before we processed it out and started selling it back as orange powder.

Every time, the discovery isn’t that science created something new. It’s that science finally caught up to what was already there.

The peptides are no different. The body is producing thousands of these messengers right now — telling itself how to function, signaling what it needs, regulating what it doesn’t. Most of them, we haven’t named. Most of them, we don’t understand. Some of them, like BRP, do exactly what we’ve been trying to manufacture for billions of dollars in pharmaceutical research.

The body was trying to tell us. We just didn’t know the language yet.

Listening Better

I’m not anti-Ozempic. I’m not telling anyone to stop taking what’s working for them. The drugs are doing real things for real people, and that matters.

But I am paying attention to the bigger story underneath all of it. The story that keeps repeating in food, in medicine, in everything. That the original recipe was usually the better one. That the body, when it works, knows what to do. That when it stops working, the answer often isn’t somewhere new — it’s somewhere we forgot to look.

The peptide wave is just getting started. There are thousands more BRPs out there, signals we haven’t decoded yet, messengers waiting to be heard. AI is going to find a lot of them in the next few years. And every one of them is going to teach us the same lesson:

The body was always the answer. We just had to learn how to listen.

Follow the remix on IG @remixology

Follow the remix on IG @remixology